Aster DM, Quality Care merge to form healthcare giant in India

INDIA—Aster DM Healthcare Limited, India’s largest integrated healthcare provider, and Quality Care India Limited have signed a definitive agreement to merge, taking a significant step towards reshaping the nation’s healthcare landscape.

 This strategic union is set to create a new entity, Aster DM Quality Care Limited, which is set  to rank among India’s top three hospital chains in terms of both revenue and bed capacity.

In this new structure, Aster DM Healthcare shareholders will command 57.3% of the merged entity, while Quality Care India shareholders will hold 42.7%.

Additionally, the joint control by Aster promoters and major private equity investors such as Blackstone, which holds 24.0%, and TPG-backed Quality Care, with a 30.7% stake, is expected to reinforce the entity’s financial strength and governance framework.

The merger, which is currently pending regulatory, corporate, and shareholder approvals, reflects a broader trend in the healthcare sector towards consolidation.

This enables companies to achieve economies of scale and more diversified service offerings.

The new merged company will combine an impressive portfolio of four prominent brands: Aster DM, CARE Hospitals, KIMSHEALTH, and Evercare.

Collectively, these brands will manage a network of 38 hospitals and boast approximately 10,150 beds across 27 major cities.

This extensive network is expected to offer significant benefits such as improved operational synergies, enhanced financial metrics, and a robust platform for future growth.

 Moreover, the merger is anticipated to be EPS accretive, which means that the combined entity could see a positive impact on its earnings per share, thus providing greater value to investors.

From a financial perspective, Aster DM Healthcare has demonstrated robust performance.

The company announced a 15% increase in revenue, totaling Rs 3138 crores (US$376.56 million) for the initial nine months of FY25.

This growth resulted from a 12% year-over-year rise in average revenue per occupied bed, alongside a 4% uptick in the number of occupied beds.

The operating EBITDA soared by 35% to Rs 613 crores (US$70.22 million), while margins rose to 19% from 16.6% last year.

Furthermore, the net profit showed an impressive 65% increase, climbing from Rs 153 crores (US$17.52 million) to Rs 251 crores (US$28.74 million) for the same period.

Disciplined cost management, operational efficiencies, and a strategic focus on a well-diversified speciality mix underpin the company’s sustained success.

This approach ensures that no single speciality contributes more than 15% of the total revenue, thereby reducing risk and bolstering the company’s resilience against market fluctuations.

In recent developments, Aster DM Healthcare has expanded its capacity by adding 100 beds at MIMS Kannur and another 100 beds at Aster Medcity, raising its total capacity to 5128 beds as of 31 December 2024.

On the market front, Aster DM Healthcare’s stock is currently trading at Rs 418(US$4.79), and numerous fund managers and industry analysts have recommended it as a strong candidate for portfolio investment.

Many brokers believe that the stock will likely appreciate significantly by Q3FY26, supported by its solid financial fundamentals and the anticipated benefits of the merger.

However, investors are encouraged to conduct their due diligence and assess their risk profiles before making investment decisions.

Sign up HERE to receive our email newsletters with the latest news and insights from Africa and beyond. Also, follow us on our WhatsApp channel for updates.